Introduction
scopy revealed no casts. Respiratory function tests showed reduction in total lung capacity, residual Sarcoidosis is a multisystem disorder characterized by volume, and transfer factor consistent with pulmonary non-caseating granulomata which most frequently presarcoid. Serum ACE level was 60 (normal range sents with bilateral hilar lymphadenopathy, pulmonary 13-40 u/l ) and 24-h urinary calcium excretion was infiltrates, and skin lesions [1 ] . Its renal manifestations within normal limits. are usually that of a granulomatous interstitial nephRenal biopsy showed two granulomata in the interritis, hypercalcaemia, and hypercalciuria and rarely a stitium but glomerular light-microscopy, immunofluoglomerulonephritis of which membranous is the most rescence, and electron-microscopy revealed only mild common [2 ] .
non-specific changes consistent with minimal-change Minimal-change disease in association with sarcoid disease. is very rare and has only been reported previously with
Prednisolone at an initial dose of 60 mg/day was other diseases (IgA [3, 4] and Graves' disease [5 ]). We commenced. This was continued for 6 weeks before report a case of steroid-resistant nephrotic syndrome being slowly tapered to 5 mg/day. After 3 months the secondary to minimal-change disease in a patient with patient still had marked proteinuria at 5.7 g/l with a sarcoidosis.
serum albumin of 24 g/l. Her exercise tolerance had improved, her serum ACE level had returned to normal, and respiratory function tests had shown some
Case report
improvement. Further investigation of the patient's 'early meno-A 43-year-old woman was admitted to our unit in pause' revealed hyperprolactinaemia, 5300 mu/l 1994 for investigation of a 2-week history of ankle (normal <600 mu/l ). MRI pituitary scan showed no swelling and shortness of breath. Sarcoidosis had been micro-or macroadenoma, and cerebrospinal fluid ACE diagnosed 14 years earlier on the basis of bilateral level was low, <5 u/l. The most likely diagnosis was nodular shadowing on X-ray, with fibrosis on lung thought to be neurosarcoidosis. She was started on biopsy. She was treated with prednisolone but this was bromocriptine but because of persistent nausea this stopped after 3 months due to problems with weight was stopped and she was commenced on hormone gain and mood swings. She experienced premature replacement therapy. menopause at 24 years. She was on no medication.
In view of her steroid-unresponsive proteinuria, the Examination revealed pitting oedema to the knees. diagnosis of minimal-change disease was queried and Blood pressure was 125/80 mmHg with no postural in March 1995 the patient underwent repeat renal drop. Respiratory, cardiovascular, neurological, and biopsy. The specimen contained 25 glomeruli, two skin examinations were normal. Initial investigations showing global sclerosis while the others were normal showed blood urea 5.1 mmol/l, creatinine 0.07 mmol/l, or had slight mesangial expansion. There were no calcium (corrected) 2.59 mmol/l, phosphate segmental sclerosing lesions. Immunofluorescence was 0.99 mmol/l, albumin 20 g/l, haemoglobin 148 g/dl, negative. Electron-microscopy was not performed. She platelets 428, total white cell count 9.4 and ESR was was commenced on cyclophosphamide at 2 mg/kg 76 mm/h. Chest X-ray revealed bilateral interstitial whilst continuing prednisolone at 5 mg/day. In July shadowing consistent with pulmonary fibrosis. Anti-DNA antibodies and ANCA were negative, comple-1995 after 3 months treatment her albumin was 24 g/l ment levels were normal and protein electrophoresis and 24-h urinary protein was 15.3 g. Due to further showed no evidence of a paraprotein. Proteinuria and problems with nausea she stopped the cyclophosphamhaematuria was present on urinalysis. Twenty-four-ide. Cyclosporin was commenced in August 1995 at an initial dose of 3 mg/kg/day. Isotope GFR measurement at that stage was 43 ml/min/1.73 m2 (serum creat-R. G. Parry et al. 2160 subjective improvement in symptoms of tiredness and A few previous reports have highlighted the association between sarcoid and minimal-change disease but nausea. In April 1996 her albumin had improved to 26 g/l with minimal proteinuria on urinalysis. The only in the context of other diseases [3] [4] [5] . This is the first report of minimal-change disease alone in a patient prednisolone was tapered and withdrawn. Her serum creatinine had deteriorated to 0.41 mmol/l by July with sarcoid. As discussed by Mü ndlein and colleagues
[5] clustering of immune disorders in individuals is 1996 and the cyclosporin was stopped. In September 1996 the lung sarcoid flared with cough and worsening well recognized and we report this case as a further example of this. respiratory function tests and she was recommenced on prednisolone 50 mg/day for 2 weeks before dose tapering. She had no flare of her nephrotic syndrome at this time.
